Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Solid Where It Matters: Questcor To Climb On Strong Quarter And Dividend Raise
Seeking Alpha
Wednesday, February 27, 2013 - 12:30pm
tags:
earnings, Questcor
ViroPharma Earnings: Here’s Why Investors are Not Happy Now
Wall St. Cheat Sheet
Wednesday, February 27, 2013 - 12:29pm
tags:
earnings, ViroPharma
Is Takeda Interested In Aastrom Bio?
Seeking Alpha
Wednesday, February 27, 2013 - 12:28pm
tags:
Takeda, Aastrom Biosciences, M&A
US Supreme Court rules against Amgen in class action
Reuters
Wednesday, February 27, 2013 - 12:26pm
tags:
Amgen, Supreme Court
The Sum Of JNJ's Parts: Medical Devices
Motley Fool
Wednesday, February 27, 2013 - 12:17pm
tags:
JNJ, devices
Roche Peels Back The Curtain On Clinical Trial Data
Pharmalot
Wednesday, February 27, 2013 - 12:16pm
tags:
Roche, clinical trials
FDA approves a pill for post-menopausal sex problems
LA Times, CA
Wednesday, February 27, 2013 - 12:15pm
tags:
FDA, Osphena, dyspareunia
Amarin: The More You Know The Fishier It Gets
Seeking Alpha
Wednesday, February 27, 2013 - 12:13pm
tags:
Amarin, Vascepa, Acasti
It's Time for This Big Pharma to Save Its Future
Motley Fool
Wednesday, February 27, 2013 - 12:11pm
tags:
AstraZeneca
Tackling Cancer: The Current and Upcoming Players
Motley Fool
Wednesday, February 27, 2013 - 11:36am
tags:
Life Technologies, JNJ, Pharmacyclics
Royalty Pharma plans to tap Elan investors on offer -source
Reuters
Wednesday, February 27, 2013 - 11:34am
tags:
Elan, investors, M&A, Royalty Pharma
Glaxo Shells Out $7.5 Million for Milestone Payment to Isis
Yahoo/Zacks
Wednesday, February 27, 2013 - 11:33am
tags:
GSK, Isis Pharmaceuticals, ISIS-TTRRx, transthyretin amyloidosis
Merck’s Tredaptive Raises Risk of Muscle Pain in Study
Bloomberg
Wednesday, February 27, 2013 - 11:31am
tags:
Tredaptive, Merck
5 Reasons To Avoid Merck
Seeking Alpha
Wednesday, February 27, 2013 - 11:29am
tags:
Merck
2 Overvalued Pseudo-Pharmaceuticals Revisited
Seeking Alpha
Wednesday, February 27, 2013 - 11:28am
tags:
TherapeuticsMD, Star Scientific
Hepatitis C In Play for 2013?
Motley Fool
Wednesday, February 27, 2013 - 11:24am
tags:
hepatitis C, BMS-986094, Bristol-Myers Squibb, Gilead, Idenix, Incivek, Achillion, Vertex Pharmaceuticals
Glaxo’s, Pfizer’s ViiV Licenses HIV Drug for Kids to Patent Pool
Bloomberg
Wednesday, February 27, 2013 - 11:22am
tags:
GSK, Pfizer, ViiV Healthcare, HIV, abacavir
FDA delay on Zogenix treatment could be positive, says Wells Fargo
The Fly on the Wall
Wednesday, February 27, 2013 - 11:20am
tags:
FDA, Zogenix, Zohydro ER
Reimbursement battle for Qsymia hits Vivus figures
Pharma Times, UK
Tuesday, February 26, 2013 - 10:55am
tags:
Vivus, reimbursement, Qsymia
Genentech Expected To Hire 600 New Employees
CBS News
Tuesday, February 26, 2013 - 10:53am
tags:
hirings, Genentech

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.